Medical School Beijing Medical University Graduated: 1983 Medical School Seton Hall University School Graduate Medical Education Graduated: 1999 Medical School Seton Hall University School Graduate Medical Education Graduated: 2002 Medical School Seton Hall University School Graduate Medical Education Graduated: 2003
Dr. Ma graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1983. She works in Edison, NJ and specializes in Neurology and Epileptologist. Dr. Ma is affiliated with John F Kennedy Medical Center.
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology) American Board of Psychiatry and Neurology Sub-certificate in Clinical Neurophysiology (Psychiatry and Neurology) American Board of Psychiatry and Neurology Sub-certificate in Neuromuscular Medicine (Psychiatry and Neurology)
Name / Title
Company / Classification
Phones & Addresses
Wei Ma Principal
The Mountwealth Group LLC Business Services
1480 Us Hwy 46, Parsippany, NJ 07054
Wei Wei Ma
Wei Ma MD Neurologist · Pediatric Neurologist
65 James St, Edison, NJ 08820 (732)3217010
Wei W. Ma Neurology
J F K Johnson Rehabilition Institute Rehabilitation Center
65 James St, Edison, NJ 08820 PO Box 3059, Edison, NJ 08818 (732)3217070
LITTLEBOX INC Chicago, IL Aug 2013 to Jan 2014 Financial AnalystBANK OF NINGXIA YinChuan, CN Mar 2012 to Jun 2012 Manager AssistantEHV BRANCH of NINGXIA ELECTRIC POWER CORPORATION YinChuan, CN Jul 2007 to Jun 2010 Financial Specialist
Education:
ILLINOIS INSTITUTE OF TECHNOLOGY Chicago, IL 2014 Master of Science in Finance concentrating on risk managementUNIVERSITY OF HULL Kingston, NY Feb 2011 Master of Business Administration in Supply Chain Management, Human Resource Management, Marketing, Accounting and FinanceNORTH CHINA ELECTRIC POWER UNIVERSITY Jul 2007 B.S. in Electrical Engineering and AutomationChartered Management Institute
Skills:
MATLAB, SPSS, VBA, SAS, MS office, CFA level 1 Candidate and FRM level 1
Us Patents
Quinazoline Derivatives For The Treatment Of Cancer
Kenneth He Huang - Chapel Hill NC, US James Veal - Apex NC, US Thomas Barta - Carrboro NC, US Emilie D. Smith - Apex NC, US Wei Ma - Cary NC, US Andy Ommen - Durham NC, US
Assignee:
Serenex, Inc. - Durham NC
International Classification:
A61K 31/517
US Classification:
5142662, 544292, 5483625, 548510
Abstract:
The current invention is directed toward compounds and pharmaceutically acceptable salts of Formula I.
Disclosed are compounds and pharmaceutically acceptable salts of Formula I, wherein A, R, X, X, X, Y, and n are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
Kenneth Huang - Chapel Hill NC, US Philip Hughes - Chapel Hill NC, US Wei Ma - Cary NC, US Andy Ommen - Durham NC, US Angela Woodward - Durham NC, US James Veal - Apex NC, US Thomas Barta - Carrboro NC, US
Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein A, Q, Q, Q, R, and Rare as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
Tetrahydroindole And Tetrahydroindazole Derivatives
Kenneth He Huang - Chapel Hill NC, US Andy J. Ommen - Durham NC, US Thomas E. Barta - Carrboro NC, US Philip F. Hughes - Chapel Hill NC, US James Veal - Apex NC, US Wei Ma - Cary NC, US Emilie D. Smith - Apex NC, US Angela R. Woodward - Durham NC, US W. Stephen McCall - Raleigh NC, US
The invention provides indole and indazole compounds of Formula (I)or pharmaceutically acceptable salts thereof which are useful for treating and/or preventing diseases and/or disorders ameliorated by the inhibition of Heat-Shock Protein 90. The invention further provides pharmaceutical compositions comprising compounds of Formula (I) and methods of preparing compounds of Formula (I).
- Blue Bell PA, US Akihiro Hashimoto - Branford CT, US Wei Ma - Cary NC, US Lee M. Katrincic - Durham NC, US
Assignee:
Achillion Pharmaceuticals, Inc. - Blue Bell PA
International Classification:
C07D 401/14
Abstract:
This invention provides stable, highly crystalline forms of Complement factor D inhibitors Compound 1 and Compound 2 for advantageous therapeutic pharmaceutical efficacy and dosage form stability.